Caitlin Hardman

Caitlin Hardman

Auto-generated profile, based on publicly available information

Caitlin Hardman

Ipswich Hospital, Ipswich, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2021 in Australasian Journal on Ageing
Verified
Journal Article
Closed access
PDF file
WTWilliam A. Tumusiime
William A. Tumusiime
CHCaitlin J. Hardman
Caitlin J. Hardman
JBJuanita Louise Breen
Juanita Louise Breen

16 July 2022 in Drug Safety
Verified
Journal Article
Open access
PDF file
WTWilliam Tumusiime
William Tumusiime
CHCaitlin Hardman
Caitlin Hardman
EMElizabeth McCourt
Elizabeth McCourt
Introduction Opioid prescribing rates are continuing to increase in Australia in line with prescribing rates seen internationally. Prescribing limits are one policy strategy to reduce short-term opioid prescribing, but there is limited evidence of their impact. Objective The aim of this study was to assess the impact of state and national policy interventions on changes to oxycodone 5 mg discharge prescriptions in public hospitals using electronic prescribing in Queensland, Australia by evaluating the proportion of oxycodone 5 mg discharge prescriptions written for ≤ 10 tablets across the study period. Method This research utilised a retrospective uncontrolled interrupted time-series design and was undertaken at 12 public hospitals using electronic prescribing from December 2018 to February 2021. The study analysed the impact of two sequential policy interventions that limited the recommended quantity of oxycodone 5 mg on discharge for all hospitalised patients. The first state-wide policy came into effect on 19 September 2019 and the second national policy came into effect on 1 June 2020. Results Over the 27-month period, there were 110,728 discharge prescriptions written in the 12 Queensland hospitals for oxycodone 5 mg. During the baseline period, approximately 50.7% (95% CI 49.5–51.8) of all oxycodone 5 mg prescriptions were from tablet quantities of ≤ 10 tablets. After the implementation of the state-wide policy, the proportion increased by 9% (95% CI 7.4–10.7; p = 0.001). The implementation of the national policy increased the proportion of oxycodone 5 mg prescriptions written for ≤10 tablets by 9.8% (95% CI 8.1–11.5; p < 0.001). Conclusions Restrictive prescribing policies at a state and national level may have resulted in decreased quantities of oxycodone 5 mg prescriptions provided on discharge from public hospitals using electronic prescribing in Queensland, Australia. Despite these positive results, continued multi-faceted policy efforts and individual tailored interventions are necessary to ensure safe and judicious opioid prescribing.

1 May 2026 in JAPhA Practice Innovations
Verified
Journal Article
Open access
WTWilliam Tumusiime
William Tumusiime
CHCaitlin Hardman
Caitlin Hardman